Hachem RY, Chemaly RF, Ahmar CA, et al. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. „Antimicrob. Agents Chemother.”. 51 (6), s. 1905-1911, 2007. DOI: 10.1128/AAC.01015-06. PMID: 17387153.
Wang SS, FitzSimmons SC, O’Leary LA, Rock MJ, Gwinn ML, Khoury MJ. Early diagnosis of cystic fibrosis in the newborn period and risk of Pseudomonas aeruginosa acquisition in the first 10 years of life: A registry-based longitudinal study. „Pediatrics”. Feb;107(2), s. 274-9, 2001. PMID: 11158458.
Yahr TL, Greenberg EP. The genetic basis for the commitment to chronic versus acute infection in Pseudomonas aeruginosa. „Mol Cell.”. Nov 19;16(4), s. 497-8, 2004. PMID: 15546607.
Smallman LA, Hill SL, Stockley RA. Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. „Thorax.”. Sep;39(9), s. 663-7, 1984. PMID: 6382675.
Plotkowski MC, Beck G, Tournier JM, Bernardo-Filho M, Marques EA, Puchelle E. Adherence of Pseudomonas aeruginosa to respiratory epithelium and the effect of leucocyte elastase. „J Med Microbiol.”. Dec;30(4), s. 285-93, 1989. PMID: 2574749.
de Bentzmann S, Roger P, Dupuit F, Bajolet-Laudinat O, Fuchey C, Plotkowski MC, Puchelle E. Asialo GM1 is a receptor for Pseudomonas aeruginosa adherence to regenerating respiratory epithelial cells. „Infect Immun.”. May;64(5), s. 1582-8, 1996. PMID: 8613364.
Davies J, Dewar A, Bush A, Pitt T, Gruenert D, Geddes DM, Alton EW. Reduction in the adherence of Pseudomonas aeruginosa to native cystic fibrosis epithelium with anti-asialoGM1 antibody and neuraminidase inhibition. „Eur Respir J.”. Mar;13(3), s. 565-70, 1999. PMID: 10232427.
Smith JJ, Travis SM, Greenberg EP, Welsh MJ. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. „Cell.”. Apr 19;85(2), s. 229-36, 1996. PMID: 8612275.
Pier GB, Grout M, Zaidi TS, Olsen JC, Johnson LG, Yankaskas JR, Goldberg JB. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. „Science.”. Jan 5;271(5245), s. 64-7, 1996. PMID: 8539601.
Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. „Proc Natl Acad Sci U S A.”. Oct 28;94(22), s. 12088-93, 1997. PMID: 9342367.
Coleman FT, Mueschenborn S, Meluleni G, Ray C, Carey VJ, Vargas SO, Cannon CL, Ausubel FM, Pier GB. Hypersusceptibility of cystic fibrosis mice to chronic Pseudomonas aeruginosa oropharyngeal colonization and lung infection. „Proc Natl Acad Sci U S A.”. Feb 18;100(4), s. 1949-1954, 2003. PMID: 12578988.
Hachem RY, Chemaly RF, Ahmar CA, et al. Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patients. „Antimicrob. Agents Chemother.”. 51 (6), s. 1905-1911, 2007. DOI: 10.1128/AAC.01015-06. PMID: 17387153.
Kaneko Y, Thoendel M, Olakanmi O, Britigan BE, Singh PK. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. „J Clin Invest.”. kwiecień;117(4), s. 877-88, 2007. PMID: 17364024.
Urszula Łopaciuk, Aleksandra Tukendorf. Pseudomonas aeruginosa. „Medycyna po Dyplomie”. 24 (7–8(232–233)), s. 82–5, lipiec-sierpień 2015. ISSN1231-1812.
Cieślik K, Pabiańczyk R, Pasternak A, Rany oparzeniowe zakażone Pseudomonas aeruginosa – ocena występowania pozytywnych hodowli w zależności od zastosowania swoistej szczepionki Oddział Leczenia Oparzeń i Chirurgii Plastycznej, Wojewódzki Szpital Specialistyczny im. Ludwika Rydygiera w Krakowie. Leczenie Ran 2008;(1):1-6; ISSN1733-4301.
